Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
ZYME
ZYME
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ZYME News
GT Biopharma Integrates AI to Accelerate Drug Development
2d ago
PRnewswire
Theravance Biopharma Acquired by Zymeworks for $17.00 per Share
Jun 29 2026
stocktwits
Zymeworks Acquires Theravance Biopharma for $929M
Jun 29 2026
seekingalpha
Zymeworks Acquires Theravance Biopharma for $929 Million
Jun 29 2026
Newsfilter
Gandeeva and Zymeworks Partner to Enhance Antibody Drug Discovery
Jun 18 2026
PRnewswire
ZW191 Shows Significant Anti-Tumor Activity in Platinum-Resistant Ovarian Cancer Patients
Jun 14 2026
Newsfilter
Zymeworks to Participate in Upcoming Investor Conferences
May 13 2026
Newsfilter
Zymeworks' ZW191 Shows Promising Efficacy in Phase 1 Trials
Apr 22 2026
NASDAQ.COM
Zymeworks Showcases Next-Generation ADC Programs at AACR 2026
Apr 17 2026
Newsfilter
Zymeworks to Report Q1 2026 Financial Results on May 7
Apr 16 2026
Newsfilter
Zymeworks Appoints New Heads of R&D and Business
Apr 09 2026
Newsfilter
Zymeworks Appoints Kristin Stafford as CFO Effective April 2026
Apr 01 2026
seekingalpha
Zymeworks Appoints New CFO, Stock Rises
Apr 01 2026
NASDAQ.COM
Zymeworks Appoints Kristin Stafford as CFO
Apr 01 2026
Newsfilter
Zymeworks' Investigational Drug ZW191 Receives FDA Fast Track Designation
Mar 30 2026
NASDAQ.COM
Zymeworks Receives FDA Fast Track Designation for ZW191
Mar 30 2026
NASDAQ.COM
Show More News
